Free CME from PeerView


Oncology CME

Credits: 1 CME / MOC / NCPD
PVI, PeerView Institute for Medical Education
Putting a Personalized Colorectal Cancer Treatment Algorithm Into Practice: Navigating Practicalities in the Era of Molecularly Defined Care
October 13, 2021
Credits: 1.00 CME / MOC / NCPD
Medical Learning Institute, Inc.
Interprofessional Perspectives on Safety Management With Targeted Therapy for B-Cell Malignancies
October 4, 2021
Credits: 1.00 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Breaking Therapeutic Barriers in RRMM: Team-Based Solutions for Integrating Novel Antibody Platforms and Improving Myeloma Care
October 1, 2021
Credits: 1.5 CME / MOC / CC
Medical Learning Institute, Inc.
Evolving Standards in Biomarker Testing, Scoring, and Results Interpretation Driven by the Broadening Role of Cancer Immunotherapy
September 28, 2021
Credits: 0.75 CME / MOC / NCPD / CPE
PVI, PeerView Institute for Medical Education
Collaborative Strategies for Managing VOD/SOS: Interprofessional Insights on Advances in Diagnosis, Severity Grading, and Treatment
September 24, 2021
Credits: 0.50 CME / MOC / CC
Medical Learning Institute, Inc.
Secondary AML Through the Microscope: A Pathology-Informed Guide to Modern Diagnostic and Treatment Principles
September 20, 2021
Credits: 1 CME / MOC
Medical Learning Institute, Inc.
Harnessing the Potential of HER2-, HER3-, and TROP2-Targeted Therapies to Address Unmet Needs in Advanced NSCLC
September 14, 2021
Credits: 1.25 CME / MOC
Medical Learning Institute, Inc.
Understanding the Clinical Spectrum of Myelofibrosis: Expert Perspectives on Molecular Biology, JAK Inhibitors, and Emerging Therapeutics
September 10, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Seizing the Day With BTK Inhibitors in CLL: Evidence-Informed Therapy Selection, Safety, and Sequential Care
September 9, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Visualizing the Present and Future of CLL: How Innovative Therapies and State-of-the-Art Combinations Are Transforming Patient Care
September 7, 2021
Credits: 1.00 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Redrawing the Algorithm in Gastric and GEJ Cancers: Treatment Planning and Sequencing in the Era of Immunotherapy
August 23, 2021
Credits: 1.00 NCPD
Medical Learning Institute, Inc.
Taking the Fight to AML: Oncology Nurse Perspectives, Principles, and Practice in an Era of Innovative Therapies
August 18, 2021
Alok A. Khorana, MD, FACP, FASCO / Robert D. McBane, II, MD
Credits: 0.75 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Reducing the Global Burden of Cancer-Associated VTE: Applying Guideline-Concordant, Evidence-Based Care and Shared Decision-Making Strategies to Improve Patient Outcomes
August 10, 2021
Jason J. Luke, MD, FACP / Geoffrey T. Gibney, MD
Credits: 1.00 CME / MOC
Medical Learning Institute, Inc.
Building Better Models for Melanoma Care: Continued Progress With Immunotherapy in Resectable and Unresectable Disease
July 7, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Innovation at Warp Speed for Multiple Myeloma: Tumor Board Insights on State-of-the-Art Care
July 7, 2021
Credits: 1.50 CME / MOC / NCPD
Medical Learning Institute, Inc.
The Expanding Advanced Ovarian Cancer Treatment Palette: Candid Conversations on Bringing PARP Inhibitors Into Clinical Practice
July 6, 2021
Credits: 1.5 CME / MOC / CC / NCPD
Medical Learning Institute, Inc.
Tracking All the Targets in Genomically Altered NSCLC: Everything You Need to Know About Biomarker Testing and Treatment
July 5, 2021
Credits: 1.50 CME / MOC
PVI, PeerView Institute for Medical Education
Rethinking the Care of Renal Cell Carcinoma: Expert Perspectives on Novel Agents, Combinations, and Sequencing Therapy
July 5, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Making the Most of Treatment Advances in SCLC: New Standards, Practicalities of Care, and Hope on the Horizon
July 5, 2021
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Clinical Consults on Modern AML Therapy: Where Precision Care Meets Potent Therapeutics
July 5, 2021

Pages